Literature DB >> 24384575

Marijuana and lung diseases.

Manish Joshi1, Anita Joshi, Thaddeus Bartter.   

Abstract

PURPOSE OF REVIEW: Cannabis sativa (marijuana) is used throughout the world, and its use is increasing. In much of the world, marijuana is illicit. While inhalation of smoke generated by igniting dried components of the plant is the most common way marijuana is used, there is concern over potential adverse lung effects. The purpose of this review is to highlight recent studies that explore the impact upon the respiratory system of inhaling marijuana smoke. RECENT
FINDINGS: Smoking marijuana is associated with chronic bronchitis symptoms and large airway inflammation. Occasional use of marijuana with low cumulative use is not a risk factor for the development of chronic obstructive pulmonary disease. The heavy use of marijuana alone may lead to airflow obstruction. The immuno-histopathologic and epidemiologic evidence in marijuana users suggests biological plausibility of marijuana smoking as a risk for the development of lung cancer; at present, it has been difficult to conclusively link marijuana smoking and cancer development.
SUMMARY: There is unequivocal evidence that habitual or regular marijuana smoking is not harmless. A caution against regular heavy marijuana usage is prudent. The medicinal use of marijuana is likely not harmful to lungs in low cumulative doses, but the dose limit needs to be defined. Recreational use is not the same as medicinal use and should be discouraged.

Entities:  

Mesh:

Year:  2014        PMID: 24384575     DOI: 10.1097/MCP.0000000000000026

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  22 in total

1.  Effects of quitting cannabis on respiratory symptoms.

Authors:  Robert J Hancox; Hayden H Shin; Andrew R Gray; Richie Poulton; Malcolm R Sears
Journal:  Eur Respir J       Date:  2015-04-02       Impact factor: 16.671

Review 2.  Risks associated with the non-medicinal use of cannabis.

Authors:  Eva Hoch; Udo Bonnet; Rainer Thomasius; Florian Ganzer; Ursula Havemann-Reinecke; Ulrich W Preuss
Journal:  Dtsch Arztebl Int       Date:  2015-04-17       Impact factor: 5.594

3.  Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting.

Authors:  Mary Barna Bridgeman; Daniel T Abazia
Journal:  P T       Date:  2017-03

Review 4.  Marijuana Legalization: Impact on Physicians and Public Health.

Authors:  Samuel T Wilkinson; Stephanie Yarnell; Rajiv Radhakrishnan; Samuel A Ball; Deepak Cyril D'Souza
Journal:  Annu Rev Med       Date:  2015-10-19       Impact factor: 13.739

5.  Medicinal cannabis: time to lighten up?

Authors:  David N Juurlink
Journal:  CMAJ       Date:  2014-06-23       Impact factor: 8.262

Review 6.  Management of chronic obstructive pulmonary disease-A position statement of the South African Thoracic Society: 2019 update.

Authors:  Mohamed Sabeer Abdool-Gaffar; Gregory Calligaro; Michelle Lianne Wong; Clifford Smith; Umesh Gangaram Lalloo; Coenraad Frederik Nicolaas Koegelenberg; Keertan Dheda; Brian William Allwood; Akhter Goolam-Mahomed; Richard Nellis van Zyl-Smit
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

7.  High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada.

Authors:  Stephanie Lake; Thomas Kerr; Rielle Capler; Jeannie Shoveller; Julio Montaner; M-J Milloy
Journal:  Int J Drug Policy       Date:  2017-03-21

Review 8.  The Impact of Cannabis Use Disorder on Suicidal and Nonsuicidal Self-Injury in Iraq/Afghanistan-Era Veterans with and without Mental Health Disorders.

Authors:  Nathan A Kimbrel; Eric C Meyer; Bryann B DeBeer; Suzy B Gulliver; Sandra B Morissette
Journal:  Suicide Life Threat Behav       Date:  2017-03-13

9.  Marijuana use trajectories during college predict health outcomes nine years post-matriculation.

Authors:  Amelia M Arria; Kimberly M Caldeira; Brittany A Bugbee; Kathryn B Vincent; Kevin E O'Grady
Journal:  Drug Alcohol Depend       Date:  2015-12-23       Impact factor: 4.492

Review 10.  Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data.

Authors:  Michael H Andreae; George M Carter; Naum Shaparin; Kathryn Suslov; Ronald J Ellis; Mark A Ware; Donald I Abrams; Hannah Prasad; Barth Wilsey; Debbie Indyk; Matthew Johnson; Henry S Sacks
Journal:  J Pain       Date:  2015-09-09       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.